ATM and cancer: Loss-of-function mutation in ATM is one of the causes of cancer, and ERK5 deletion in ATM-/- mice has been shown to delay tumorigenesis and increase response to DNA-targeting agents via H2AX phosphorylation in thymic lymphoma [27].